Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Market Attractiveness

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Antibody Drug Conjugates Market - Key Industry Dynamics

4.1 Key Market Drivers:

4.1.1 Growing Strategic Partnerships to Develop Antibody Drug Conjugates

4.1.2 Rising Incidences of Cancer Cases

4.1.3 Increasing FDA Approvals for ADCs

4.2 Market Restraints

4.2.1 High Cost of ADCs Development and Commercialization

4.3 Market Opportunities

4.3.1 Increasing Investments to Develop ADCs

4.4 Market Trends

4.4.1 Escalating Pipeline of ADCs

4.5 Impact Analysis:

5. Antibody Drug Conjugates Market - South & Central America Market Analysis

5.1 South & Central America Antibody Drug Conjugates Market Revenue (US$ Mn), 2017 - 2030

6. South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Technology

6.1 Overview

6.2 South & Central America Antibody Drug Conjugates Market Revenue Share, by Technology 2022 & 2030 (%)

6.3 Cleavable Linker

6.3.1 Overview

6.3.2 Cleavable Linker: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Non-cleavable Linker

6.4.1 Overview

6.4.2 Non-cleavable Linker: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 South & Central America Antibody Drug Conjugates Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Blood Cancer

7.3.1 Overview

7.3.2 Blood Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Breast Cancer

7.4.1 Overview

7.4.2 Breast Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Ovarian Cancer

7.5.1 Overview

7.5.2 Ovarian Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Urothelial Cancer

7.6.1 Overview

7.6.2 Urothelial Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 - by Distribution Channel

8.1 Overview

8.2 South & Central America Antibody Drug Conjugates Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

8.3 Hospital Pharmacies

8.3.1 Overview

8.3.2 Hospital Pharmacies: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Retail Pharmacies

8.4.1 Overview

8.4.2 Retail Pharmacies: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Online Pharmacies

8.5.1 Overview

8.5.2 Online Pharmacies: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Antibody Drug Conjugates Market - Country Analysis

9.1 South & Central America Antibody Drug Conjugates Market, Revenue and Forecast To 2030

9.1.1 Overview

9.1.2 South & Central America Antibody Drug Conjugates Market Breakdown, by Country- Revenue (2022) (US$ Million)

9.1.3 South & Central America: Antibody Drug Conjugates Market, by Countries, 2022 and 2030 (%)

9.1.3.1 Brazil

9.1.3.1.1 Overview

9.1.3.1.2 Brazil: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.1.3 Brazil: Antibody Drug Conjugates Market, by Technology

9.1.3.1.4 Brazil: Antibody Drug Conjugates Market, by Application

9.1.3.1.5 Brazil: Antibody Drug Conjugates Market, by Distribution Channel

9.1.3.2 Argentina

9.1.3.2.1 Overview

9.1.3.2.2 Argentina: Antibody Drug Conjugates Market, by Technology

9.1.3.2.3 Argentina: Antibody Drug Conjugates Market, by Application

9.1.3.2.4 Argentina: Antibody Drug Conjugates Market, by Distribution Channel

9.1.3.3 Rest of South & Central America

9.1.3.3.1 Overview

9.1.3.3.2 Rest of South & Central America: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

9.1.3.3.3 Rest of South & Central America: Antibody Drug Conjugates Market, by Technology

9.1.3.3.4 Rest of South & Central America: Antibody Drug Conjugates Market, by Application

9.1.3.3.5 Rest of South & Central America: Antibody Drug Conjugates Market, by Distribution Channel

10. Antibody Drug Conjugates Market-Industry Landscape

10.1 Overview

10.2 Organic Growth Strategies

10.2.1 Overview

10.3 Inorganic Growth Strategies

10.3.1 Overview

10.4 Companies' Manufacturing Capacities and Capabilities

11. Company Profiles

11.1 Pfizer Inc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Hoffmann-La Roche Ltd

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 GSK Plc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Gilead Sciences Inc

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 AstraZeneca Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Astellas Pharma Inc

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Takeda Pharmaceutical Co Ltd

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. South & Central America Antibody Drug Conjugates Market Segmentation

Table 2. New Cancer Cases Worldwide, in 2020

Table 3. List of FDA-Approved ADCs

Table 4. Brazil: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology

Table 5. Brazil: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 6. Brazil: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel

Table 7. Argentina: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology

Table 8. Argentina: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 9. Argentina: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel

Table 10. Rest of South & Central America: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Technology

Table 11. Rest of South & Central America: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Application

Table 12. Rest of South & Central America: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn) - Distribution Channel

Table 13. Recent Organic Growth Strategies in Antibody Drug Conjugates Market

Table 14. Recent Inorganic Growth Strategies in the Antibody Drug Conjugates Market

Table 15. Glossary of Terms, Antibody Drug Conjugates Market

List of Figures

Figure 1. South & Central America Antibody Drug Conjugates Market Segmentation, By Country

Figure 2. Key Insights

Figure 3. South & Central America Antibody Drug Conjugates Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. South & Central America Antibody Drug Conjugates Market Revenue (US$ Mn), 2017 - 2030

Figure 6. South & Central America Antibody Drug Conjugates Market Revenue Share, by Technology 2022 & 2030 (%)

Figure 7. Cleavable Linker: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Non-Cleavable Linker: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. South & Central America Antibody Drug Conjugates Market Revenue Share, by Application 2022 & 2030 (%)

Figure 10. Blood Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Breast Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Ovarian Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Urothelial Cancer: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Others: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. South & Central America Antibody Drug Conjugates Market Revenue Share, by Distribution Channel 2022 & 2030 (%)

Figure 16. Hospital Pharmacies: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Retail Pharmacies: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Online Pharmacies: South & Central America Antibody Drug Conjugates Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. South & Central America Antibody Drug Conjugates, by Key Country - Revenue (2022) (US$ Million)

Figure 20. South & Central America: Antibody Drug Conjugates Market, By Key Countries, 2022 And 2030 (%)

Figure 21. Brazil: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

Figure 22. Argentina: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)

Figure 23. Rest of South & Central America: Antibody Drug Conjugates Market Revenue and Forecast to 2030 (US$ Mn)